Fengfeng Bei
Overview
Explore the profile of Fengfeng Bei including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
701
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yao Y, Bei F
Adv Neurobiol
. 2024 Nov;
41:91-112.
PMID: 39589711
Recombinant adeno-associated viruses (AAVs) have emerged as a popular tool for gene therapy in the central nervous system (CNS). Given the dense vasculature in the CNS, systemic administration is an...
2.
Xu L, Yao S, Ding Y, Xie M, Feng D, Sha P, et al.
J Transl Med
. 2024 Sep;
22(1):866.
PMID: 39334366
Recombinant adeno-associated viruses (rAAVs) have emerged as an attractive tool for gene delivery, and demonstrated tremendous promise in gene therapy and gene editing-therapeutic modalities with potential "one-and-done" treatment benefits compared...
3.
Bhere D, Arghiani N, Lechtich E, Yao Y, Alsaab S, Bei F, et al.
Sci Rep
. 2024 Jul;
14(1):15303.
PMID: 38961123
No abstract available.
4.
Sangster M, Bishop M, Yao Y, Feitor J, Shahriar S, Miller M, et al.
Mol Ther Methods Clin Dev
. 2024 Jun;
32(2):101269.
PMID: 38934011
Mucolipidosis IV (MLIV) is a rare, autosomal recessive, lysosomal disease characterized by intellectual disability, motor deficits, and progressive vision loss. Using adeno-associated vector 9 (AAV9) and AAV-PHP.B as delivery vectors,...
5.
Yao Y, Wang J, Liu Y, Qu Y, Wang K, Zhang Y, et al.
Nat Biomed Eng
. 2022 Oct;
6(11):1257-1271.
PMID: 36217021
The development of gene therapies for the treatment of diseases of the central nervous system has been hindered by the limited availability of adeno-associated viruses (AAVs) that efficiently traverse the...
6.
Yonar M, Uehara M, Banouni N, Kasinath V, Li X, Jiang L, et al.
Transplant Direct
. 2020 Aug;
6(8):e589.
PMID: 32766437
Background: Organ transplantation is a standard therapeutic strategy for irreversible organ damage, but the utility of nerve transplantation remains generally unexplored, despite its potential benefit to a large patient population....
7.
Bhere D, Arghiani N, Lechtich E, Yao Y, Alsaab S, Bei F, et al.
Sci Rep
. 2020 Feb;
10(1):1779.
PMID: 32019988
Dysregulation of miRNA expression has been implicated in cancer. Numerous strategies have been explored to modulate miR but sub-optimal delivery and inability to concurrently target multiple pathways involved in tumor...
8.
Bhaskaran V, Yao Y, Bei F, Peruzzi P
Nat Protoc
. 2019 Nov;
14(12):3538-3553.
PMID: 31748752
The cellular machinery regulating microRNA biogenesis and maturation relies on a small number of simple steps and minimal biological requirements and is broadly conserved in all eukaryotic cells. The same...
9.
Norsworthy M, Bei F, Kawaguchi R, Wang Q, Tran N, Li Y, et al.
Neuron
. 2017 Jun;
94(6):1112-1120.e4.
PMID: 28641110
At least 30 types of retinal ganglion cells (RGCs) send distinct messages through the optic nerve to the brain. Available strategies of promoting axon regeneration act on only some of...
10.
Cartoni R, Norsworthy M, Bei F, Wang C, Li S, Zhang Y, et al.
Neuron
. 2017 May;
94(3):689.
PMID: 28472662
No abstract available.